Biodesix, Inc. (BDSX)

USD 1.34

(-3.6%)

Gross Profit Summary of Biodesix, Inc.

  • Biodesix, Inc.'s latest annual gross profit in 2023 was 36.07 Million USD , up 38.05% from previous year.
  • Biodesix, Inc.'s latest quarterly gross profit in 2024 Q2 was 14.04 Million USD , up 20.66% from previous quarter.
  • Biodesix, Inc. reported a annual gross profit of 24.05 Million USD in annual gross profit 2022, up 0.29% from previous year.
  • Biodesix, Inc. reported a annual gross profit of 23.98 Million USD in annual gross profit 2021, up 1.82% from previous year.
  • Biodesix, Inc. reported a quarterly gross profit of 11.64 Million USD for 2024 Q1, up 3.09% from previous quarter.
  • Biodesix, Inc. reported a quarterly gross profit of 13.97 Million USD for 2024 Q3, down -0.54% from previous quarter.

Annual Gross Profit Chart of Biodesix, Inc. (2023 - 2018)

Historical Annual Gross Profit of Biodesix, Inc. (2023 - 2018)

Year Gross Profit Gross Profit Growth
2023 36.07 Million USD 38.05%
2022 24.05 Million USD 0.29%
2021 23.98 Million USD 1.82%
2020 23.55 Million USD 27.5%
2019 18.47 Million USD 15.3%
2018 16.02 Million USD 0.0%

Peer Gross Profit Comparison of Biodesix, Inc.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD -277.138%
Prenetics Global Limited 8.82 Million USD -308.578%
Star Equity Holdings, Inc. 11.92 Million USD -202.507%
CareDx, Inc 178.32 Million USD 79.769%
Exact Sciences Corporation 1.84 Billion USD 98.045%
Exagen Inc. 29.45 Million USD -22.478%
Inotiv, Inc. 165.44 Million USD 78.194%
Guardant Health, Inc. 336.89 Million USD 89.291%
BioNexus Gene Lab Corp. 1.32 Million USD -2613.581%
Precipio, Inc. 6.01 Million USD -499.485%
iSpecimen Inc. 5.1 Million USD -606.296%
Natera, Inc. 492.74 Million USD 92.678%
Aspira Women's Health Inc. 5.26 Million USD -585.614%
Standard BioTools Inc. 50.45 Million USD 28.49%
23andMe Holding Co. 99.37 Million USD 63.697%
Castle Biosciences, Inc. 174.8 Million USD 79.362%
Personalis, Inc. 18.2 Million USD -98.138%
Aclaris Therapeutics, Inc. 13.16 Million USD -173.975%
Applied DNA Sciences, Inc. 5.53 Million USD -551.982%
OpGen, Inc. -90.69 Thousand USD 39878.817%
T2 Biosystems, Inc. -8.17 Million USD 541.579%
Myriad Genetics, Inc. 476.4 Million USD 92.427%
ICON Public Limited Company 1.81 Billion USD 98.011%
NeoGenomics, Inc. 244.6 Million USD 85.251%
Star Equity Holdings, Inc. 11.92 Million USD -202.507%
IDEXX Laboratories, Inc. 2.18 Billion USD 98.353%
RadNet, Inc. 93 Million USD 61.208%
MDxHealth SA 43.92 Million USD 17.874%
Psychemedics Corporation 8.41 Million USD -328.824%
Illumina, Inc. 2.74 Billion USD 98.685%
Check-Cap Ltd. -212 Thousand USD 17117.453%
Twist Bioscience Corporation 133.34 Million USD 72.945%
DarioHealth Corp. 5.98 Million USD -502.891%
Fulgent Genetics, Inc. 104.45 Million USD 65.462%
Sera Prognostics, Inc. 96 Thousand USD -37480.208%
ENDRA Life Sciences Inc. -275.45 Thousand USD 13197.429%
OPKO Health, Inc. 318.12 Million USD 88.66%
Medpace Holdings, Inc. 524.5 Million USD 93.122%
Neogen Corporation 463.9 Million USD 92.223%
Intelligent Bio Solutions Inc. 1.42 Million USD -2430.608%
Prenetics Global Limited 8.82 Million USD -308.578%
Mainz Biomed B.V. 509.65 Thousand USD -6978.655%
bioAffinity Technologies, Inc. 791.61 Thousand USD -4457.392%
Trinity Biotech plc 19.45 Million USD -85.486%
Neuronetics, Inc. 51.7 Million USD 30.225%
Sotera Health Company 577.15 Million USD 93.749%
bioAffinity Technologies, Inc. 791.61 Thousand USD -4457.392%